𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glutamic acid decarboxylase antibodies in Satoyoshi syndrome

✍ Scribed by Gea Drost; Aad Verrips; Herbert Hooijkaas; Machiel Zwarts


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
193 KB
Volume
55
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Glutamic acid decarboxylase antibodies i
✍ Pasquale Striano; Giuseppe Perruolo; Luca Errichiello; Pietro Formisano; Frances πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 49 KB

colleagues' concern that there may be bias toward patients with more progressive disease in the control group compared with the treated group appears unlikely. The 20% of patients in the control group who had discontinued immunomodulatory or immunosuppressive treatment in the first 3 to 6 weeks bec

Response to steroid treatment in anti–gl
✍ Ji-Youn Kim; Eun Joo Chung; Jong-Hun Kim; Ki-Young Jung; Won Yong Lee πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 60 KB

Glutamic acid decarboxylase (GAD) is an enzyme that catalyzes the conversion of glutamate to β₯-aminobutyric acid (GABA). Anti-GAD antibody (GAD-Ab) is considered to be a marker for stiff person syndrome (SPS), 1 insulin-dependent diabetes mellitus (IDDM), and polyendocrine autoimmune syndrome. 2 Add

Determination of glutamic acid decarboxy
✍ P.J. Lupien; C.M. Hinse; L. Berlinguet πŸ“‚ Article πŸ“… 1968 πŸ› Elsevier Science 🌐 English βš– 424 KB

Since the decarboxylation of glutamic acid into y-aminobutyric acid (GABA) involves a release of COz, we easily understand the widespread use of manometric methods for the determination of glutamic acid decarboxylase activity (GADA) (l-13,29,30). Other investigators (14-16) have chosen to measure G